Nervous System Disorder Drugs

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/66

encourage image

There's no tags or description

Looks like no tags are added yet.

67 Terms

1
New cards

catalepsy

involuntary muscle rigidity

2
New cards

minimum alveolar concentration (MAC)

alveolar concentration of a drug that prevents gross purposeful movement in 50% of patients in response to a standardized painful stimuli

3
New cards

parasympatholytic agents

anticholinergic agents; reduce the activity of the parasympathetic nervous system

4
New cards

parasympathomimetic agents

cholinergic agents; mimic the action of acetycholine (direct-acting) or inhibit its breakdown (indirect-acting)

5
New cards

sympatholytic agents

adrenergic blocking agents; disrupt or inihibit the activity of the sympathetic nervous system

6
New cards

sympathomimetic agents

adrenergic agents; mimic the fight or flight response

7
New cards

alpha-1 receptors

constrict arterioles, increase urethral tone, dilate the pupil

8
New cards

alpha-2 receptors

constrict skeletal muscle

9
New cards

beta-1 receptors

increase heart rate, conduction and contractility and cause renin release in the kidneys

10
New cards

beta-2 receptors

dilate skeletal blood vessels and bronchioles

11
New cards

dopaminergic receptors

dilate blood vessels of kidneys, coronary vessels of the heart, and the mesenteric blood vessels

12
New cards

cholinergic agents - clinical uses

diagnose myasthenia gravis, reduce IOP of glaucoma, stimulate GI motility, treat urinary retention, control vomiting, and act as an antidote for neuromuscular blockers

13
New cards

direct-acting cholinergic agents

acetylcholine, carbamylcholine, bethanechol, pilocarpine, metoclopramide

14
New cards

indirect-acting cholinergic agents

edrophonium, neostigmine, physostigmine, organophosphate compounds, demecarium, pyridostigmine

15
New cards

cholinergic blocking agents - clinical uses

treat diarrhea and vomiting by decreasing GI motility, dry secretions and prevent bradycardia before anesthesia, dilate the pupils, relieve ciliary spasms of the eye, and treat sinus bradcardia

16
New cards

cholinergic blocking agents (anticholinergics)

atropine, methscopolamine, glycopyrrolate, aminopentamide, propantheline, pralidoxime

17
New cards

adrenergic agents - clinical uses

stimulate a heart beat during cardiac arrest, reverse hypotension and bronchoconstriction from anaphylactic shock, strengthen the heart during CHF, correct hypotension and capillary bleeding through vasoconstriction, treat urinary incontinence, reduce vasoconstriction in allergic conditions, prolong the effects of local anesthetic agents by causing vasoconstriction of blood vessels at the injection site, and treat glaucoma

18
New cards

adrenergic agents

epinephrine, norepinephrine, isoproterenol, phenylephrine, dopamine, phenylpropanolamine, dobutamine, albuterol

19
New cards

alpha blockers

phenoxybenxamine: hypotensive (vasodilator agent)

acepromazine: tranquilizier, causes vasodilation

prazosin: hypotensive agent, treats urethral spasms

yohimbine; antidote for xylazine toxicity

atipamezole: reversal agent for dexmedetomidine

20
New cards

beta blockers

treat galucoma, arrhythmias, and hypertrophic cardiomyopathy; propranolol, timolol, atenolol

21
New cards

tranquilizers

decrease anxiety without excessive sedation or drowsiness

22
New cards

phenothiazine derivatives

tranquilizers that produce sedation and allay fear and anxiety without producing significant analgesia; antiemetic effect, mild antipruritic effect, and reduces tendency of epinephrine to induce cardiac arrhythmias

23
New cards

phenothiazine derivatives - examples

acepromazine maleate, chlorpromazine HCl, promazine HCl, prochlorperazine

24
New cards

benzodiazepine derivatives

tranquilizers that produce sedation, muscle relaxation, appetite stimulation, and anticonvulsant activity; minimal depression of the cardiovascular and respiratory systems

25
New cards

benzodiazepine derivatives - examples

diazepam, midazolam, zolazepam, alprazolam

26
New cards

alpha-2 agonists

sedative analgesics; provide sedation, analgesia, muscle relaxation, and antianxiety effect

27
New cards

alpha-2 agonists - examples

xylazine HCl, detomidine HCl, medetomidine, dexmedetomidine, romifidine

28
New cards

barbiturates

CNS depressant; sedative, anticonvulsant, general anesthetic, and euthanasia agent; nonreversible and metabolized by the liver

29
New cards

barbiturates - examples

phenobarbital, pentobarbital, thiopental

30
New cards

dissociative agents

produce catalepsy, amnesia, and analgesia; pharyngeal reflexes maintained

31
New cards

dissociative agents - examples

ketamine HCl, tiletamine HCl, phencyclidine

32
New cards

opioid agonists

produce analgesia and sedation while reducing anxiety and fear

33
New cards

opioid agonists - examples

naturally occurring: opium, morphine sulfate; synthetic: meperidine, oxymorphone, butorphanol tartrate, fentanyl, hydrocodone bitartrate, etorphine, pentazocine, diphenolxylate, apomorphine, methadone, codeine, carfentanil, buprenorphine, tramadol

34
New cards

opioid receptors - mu

found in pain-regulating areas of the brain; provide analgesia, euphoria, respiratory depression, physical dependence, and hypothermic actions

35
New cards

opioid receptors - kappa

found in the cerebral cortex and spinal cord; contribute to analgesia, sedation, depression, and miosis

36
New cards

opioid receptors - sigma

struggling, whining, hallucinations, and mydriatic effects

37
New cards

opioid receptors - delta

modify mu receptor activity; contribute to analgesia

38
New cards

opioid antagonists

block the effects of opioids by binding with opiate receptors, displacing molecules already present, and preventing further binding

39
New cards

opioid antagonists - examples

naloxone, nalorphine, butorphanol

40
New cards

neuroleptanalgesic agents

an opioid and a tranquilizer; the animal may or may not remain conscious

41
New cards

neuroleptanalgesic agents - examples

fentanyl and droperidol, acepromazine and morphine, acepromazine and oxymorphone, xylazine and butorphanol

42
New cards

agents for seizure prevention or control

diazepam (Valium): tranquilizer; IV admine, 3-4 hour duration of action

pentobarbital (Nembutal): short-acting barbiturate; IV admin, 1-3 hour duration

phenobarbital (Luminal, Solfoton): oral or parenteral; Class IV

primidone (Mylepsin, Neurosyn): portion of dose metabolized to phenobarbital by the liver; oral admin

broimde: adjunct to phenobarbital or primidone therapy

gabapentin (Neurontin): adjunct for difficult to control seuzures, partial complex seizures, or pain control

levetiracetam/zonisamide (Kappra/Zonegran): adjunct for refractory canine epilepsy

43
New cards

isoflurane

inhalant anesthetic; rapid induction and recovery times, stable heart rhythm, does not decrease CO

44
New cards

sevoflurane

inhalant anesthetic; good choice for mask induction, rapid induction and recovery - used in high-risk, small-animal patients

45
New cards

halothane

inhalant anesthetic; sensitizes heart to catecholamines which may result in cardiac dysrhythmias; must be used in precision vaporizers

46
New cards

methoxyflurane

inhalant anesthetic; most potent

47
New cards

nitrous oxide

inhalant anesthetic; adjunct to more potent agents during mask induction to speed induction; lowest solubility coefficient

48
New cards

propofol

short-acting hypnotic; used for anesthetic induction before admin of an inhalant anesthetic, outpatient procedures, substitute for barbiturates in sighthounds, and patients with preexisting cardiac arrhythmias; does not cross the placental barrier

49
New cards

glyceryl guaiacolate or guaifenesin

skeletal muscle relaxant; used in equines to induce general anesthesia, extend the the activity of other injectable field anesthetics, or enhance muscle relaxation of anesthetized patients

50
New cards

doxapram

CNS stimulant; stimulates respiration in newborns and during or after anesthesia if respiratory rate and depth of respirations need to be increased

51
New cards

neuromuscular blocking drugs

interfere with neuromuscular transmission of impulses; used as an adjunct to general anesthesia or to facilitate endotracheal intubation; no analgesia or sedation

52
New cards

depolarizing neuromuscular blocking drugs

act similar to acetylcholine with longer lasting effect leading to muscle paralysis; not broken down by acetylcholinesterase, no antagonist

53
New cards

nondepolarizing neuromuscular blocking drugs

prevent acetylcholine from binding to receptor sites

54
New cards

benzodiazepines (antianxiety meds)

bind with and promote GABA activity in the cerebral cortex and subcortical areas; treat fears and phobias, separation anxiety, aggression, urine marking, and appetite stimulation

55
New cards

azapirones (antianxiety meds)

blocks serotonin receptors with no muscle relaxant, anticonvulsant, or sedative effects; controls urine spraying/marking, fearfulness, and anxiety

56
New cards

dexmedetomidine oromucosal gel

highly potent and selective alpha-2 adrenoceptor agonist; binds with the alpha-2 receptors in the brainstem to prevent the release of norepinephrine; used for noise aversion to relieve anxiety without inducing sedation

57
New cards

tricyclics

antidepressants; prevent reuptake of norepinephrine and serotonin; treat separation anxiety, obsessive disorders, fearful aggression, hyperactivity, hypervocalization, and urine marking

58
New cards

tricyclic antidepressant - examples

amitriptyline, imipramine, clomipramine

59
New cards

serotonin reuptake inhibitors

antidepressants; increase the amount of serotonin in the synapse; treat obsessive disorders, phobias, aggression, urine marking, and separation anxiety

60
New cards

serotonin reuptake inhibitors - examples

fluoxetine, sertraline, paroxetine, trazodone

61
New cards

monoamine oxidase-b inhibitors

antidepressant; block or inhibit MAO-B and allow dopamine levels to increase; treat old-dog dementia and canine Cushing’s disease

62
New cards

synthetic progestins

antidepressant; treat behavioral problems associated with changing hormonal levels such as urine spraying/marking and intermale and dominance aggression

63
New cards

synthetic progestins - examples

megestrol acetate, medroxyprogesterone

64
New cards

gapapentin

behavioral agent; treat anxiety or social phobias

65
New cards

clorazepate (Tranxene-SD)

behavioral agent; treat anxiety or social phobias; Class IV

66
New cards

methylphenidate (Ritalin)

hyperactivity in dogs; Class II

67
New cards

pentobarbital sodium

euthanasia agents; rapidly produce unconsciousness and death; main ingredient pentobarbital (Class II), may be combined with other agents (Class III)